Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Disease × Drug Delivery Systems × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Pleural Neoplasms 1 Pancreatic Cyst 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Disease 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01373671 2020-08-07

DBT

Siemens Medical Solutions USA - CSG

Phase NA Completed

764 enrolled 5 charts

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡